Evaluation of 2,6-Diamino-N-([1-(1-oxotridecyl)-2-piperidinyl]methyl) hexanamide (NPC 15437), a protein kinase C inhibitor, as a modulator of P-glycoprotein-mediated resistancein vitro
Year: 1995
Type: article
Source: Investigational New Drugs
DOI: 10.1007/bf00873134
Institutions: Johns Hopkins University, Johns Hopkins Medicine
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2034369461
